Norartocarpetin from a folk medicine Artocarpus communis plays a melanogenesis inhibitor without cytotoxicity in B16F10 cell and skin irritation in mice

BMC Complementary and Alternative Medicine

Feng-Lin Yen⁵  Chiang-Wen Lee²  Tsung-Han Yang⁴  Chan-Jung Liang¹  Chun-Ching Lin³  Ming-Hong Yen⁶  Yi-Ting Tsai⁶  Horng-Huey Ko⁵ 

[1] Department of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei, Taiwan;Department of Nursing, Division of Basic Medical Sciences, and Chronic Diseases and Health Promotion Research Center, Chang Gung Institute of Technology, Chia-Yi, Taiwan;School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan;Laboratory Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan;Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan;Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan

关键词: Mitogen-activated protein kinases;    Microphthalmia-associated transcription factor;    Tyrosinase;    Melanogenesis;    Norartocarpetin;   

Others  :  1220458
DOI  :  10.1186/1472-6882-13-348

 received in 2013-03-15, accepted in 2013-11-19,  发布年份 2013

【 摘 要 】

Background

Many natural products used in preventive medicine have also been developed as cosmeceutical ingredients in skin care products, such as Scutellaria baicalensis and Gardenia jasminoides. Norartocarpetin is one of the antioxidant and antityrosinase activity compound in Artocarpus communis; however, the cytotoxicity, skin irritation and antimelanogenesis mechanisms of norartocarpetin have not been investigated yet.

Methods

In the present study, cell viability in vitro and skin irritation in vivo are used to determine the safety of norartocarpetin. The melanogenesis inhibition of norartocarpetin was determined by cellular melanin content and tyrosinase in B16F10 melanoma cell. Moreover, we examined the related-melanogenesis protein by western blot analysis for elucidating the antimelanogenesis mechanism of norartocarpin.

Results

The result of the present study demonstrated that norartocarpetin not only present non-cytotoxic in B16F10 and human fibroblast cells but also non-skin irritation in mice. Moreover, our result also first found that norartocarpetin downregulated phospho-cAMP response element-binding (phospho-CREB) and microphthalmia-associated transcription factor (MITF) expression, which in turn decreased both synthesis of tyrosinases (TRP-1 and TRP-2) and cellular melanin content. This process is dependent on norartocarpetin phosphorylation by mitogen-activated protein kinases such as phospho-JNK and phospho-p38, and it results in decreased melanogenesis.

Conclusion

The present study suggests that norartocarpetin could be used as a whitening agent in medicine and/or cosmetic industry and need further clinical study.

【 授权许可】

   
2013 Ko et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Hunt KJ, Hung SK, Ernst E: Botanical extracts as anti-aging preparations for the skin: a systematic review. Drugs Aging 2010, 27:973-985.
• [2]Antignac E, Nohynek GJ, Re T, Clouzeau J, Toutain H: Safety of botanical ingredients in personal care products/cosmetics. Food Chem Toxicol 2011, 49:324-341.
• [3]Reuter J, Merfort I, Schempp CM: Botanicals in dermatology: an evidence-based review. Am J Clin Dermatol 2010, 11:247-267.
• [4]Baumann L, Woolery-Lloyd H, Friedman A: “Natural” ingredients in cosmetic dermatology. J Drugs Dermatol 2009, 8(Suppl 6):s5-s9.
• [5]Jarrett WF, Jennings FW, Mc IW, Mulligan W, Thomas BA, Urquhart GM: Immunological studies on Dictyocaulus viviparus infection: the immunity resulting from experimental infection. Immunology 1959, 2:252-261.
• [6]Lin JA, Fang SC, Wu CH, Huang SM, Yen GC: Anti-inflammatory effect of the 5,7,4'-trihydroxy-6-geranylflavanone isolated from the fruit of Artocarpus communis in S100B-induced human monocytes. J Agric Food Chem 2011, 59:105-111.
• [7]Wei BL, Weng JR, Chiu PH, Hung CF, Wang JP, Lin CN: Antiinflammatory flavonoids from Artocarpus heterophyllus and Artocarpus communis. J Agric Food Chem 2005, 53:3867-3871.
• [8]Zheng ZP, Chen S, Wang S, Wang XC, Cheng KW, Wu JJ, Yang D, Wang M: Chemical components and tyrosinase inhibitors from the twigs of Artocarpus heterophyllus. J Agric Food Chem 2009, 57:6649-6655.
• [9]Fang SC, Hsu CL, Yu YS, Yen GC: Cytotoxic effects of new geranyl chalcone derivatives isolated from the leaves of Artocarpus communis in SW 872 human liposarcoma cells. J Agric Food Chem 2008, 56:8859-8868.
• [10]Adewole SO, Ojewole JO: Hyperglycaemic effect of Artocarpus communis Forst (Moraceae) root bark aqueous extract in Wistar rats. Cardiovasc J Afr 2007, 18:221-227.
• [11]Khan MR, Omoloso AD, Kihara M: Antibacterial activity of Artocarpus heterophyllus. Fitoterapia 2003, 74:501-505.
• [12]Boonphong S, Baramee A, Kittakoop P, Puangsombat P: Antitubercular and antiplasmodial prenylated flavones from the roots of Artocarpus altilis. Chiang Mai J Sci 2007, 34:339-344.
• [13]Likhitwitayawuid K, Sritularak B, Benchanak K, Lipipun V, Mathew J, Schinazi RF: Phenolics with antiviral activity from Millettia erythrocalyx and Artocarpus lakoocha. Nat Prod Res 2005, 19:177-182.
• [14]Weng JR, Chan SC, Lu YH, Lin HC, Ko HH, Lin CN: Antiplatelet prenylflavonoids from Artocarpus communis. Phytochemistry 2006, 67:824-829.
• [15]Ko FN, Cheng ZJ, Lin CN, Teng CM: Scavenger and antioxidant properties of prenylflavones isolated from Artocarpus heterophyllus. Free Radic Biol Med 1998, 25:160-168.
• [16]Brenner M, Hearing VJ: The protective role of melanin against UV damage in human skin. Photochem Photobiol 2008, 84:539-549.
• [17]Rass K, Reichrath J: UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 2008, 624:162-178.
• [18]Chakraborty AK, Funasaka Y, Slominski A, Bolognia J, Sodi S, Ichihashi M, Pawelek JM: UV light and MSH receptors. Ann N Y Acad Sci 1999, 885:100-116.
• [19]Busca R, Ballotti R: Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 2000, 13:60-69.
• [20]Jang JY, Kim HN, Kim YR, Choi WY, Choi YH, Shin HK, Choi BT: Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells. J Ethnopharmacol 2011, 137:1207-1214.
• [21]Huang HC, Hsieh WY, Niu YL, Chang TM: Inhibition of melanogenesis and antioxidant properties of Magnolia grandiflora L. flower extract. BMC Complement Altern Med 2012, 12:72. BioMed Central Full Text
• [22]Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, Fisher DZ, Fisher DE: c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 2000, 14:301-312.
• [23]Haddad MM, Xu W, Schwahn DJ, Liao F, Medrano EE: Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Exp Cell Res 1999, 253:561-572.
• [24]Ye Y, Chu JH, Wang H, Xu H, Chou GX, Leung AK, Fong WF, Yu ZL: Involvement of p38 MAPK signaling pathway in the anti-melanogenic effect of San-bai-tang, a Chinese herbal formula, in B16 cells. J Ethnopharmacol 2010, 132:533-535.
• [25]Lo YH, Lin RD, Lin YP, Liu YL, Lee MH: Active constituents from Sophora japonica exhibiting cellular tyrosinase inhibition in human epidermal melanocytes. J Ethnopharmacol 2009, 124:625-629.
• [26]O'Donoghue JL: Hydroquinone and its analogues in dermatology - a risk-benefit viewpoint. J Cosmet Dermatol 2006, 5:196-203.
• [27]Manini P, Napolitano A, Westerhof W, Riley PA, d'Ischia M: A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity. Chem Res Toxicol 2009, 22:1398-1405.
• [28]Yang YM, Son YO, Lee SA, Jeon YM, Lee JC: Quercetin inhibits alpha-MSH-stimulated melanogenesis in B16F10 melanoma cells. Phytother Res 2011, 25:1166-1173.
• [29]Kim DC, Rho SH, Shin JC, Park HH, Kim D: Inhibition of melanogenesis by 5,7-dihydroxyflavone (chrysin) via blocking adenylyl cyclase activity. Biochem Biophys Res Commun 2011, 411:121-125.
• [30]Bu J, Ma PC, Chen ZQ, Zhou WQ, Fu YJ, Li LJ, Li CR: Inhibition of MITF and tyrosinase by paeonol-stimulated JNK/SAPK to reduction of phosphorylated CREB. Am J Chin Med 2008, 36:245-263.
• [31]Tu CX, Lin M, Lu SS, Qi XY, Zhang RX, Zhang YY: Curcumin inhibits melanogenesis in human melanocytes. Phytother Res 2012, 26:174-179.
• [32]Solano F, Briganti S, Picardo M, Ghanem G: Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 2006, 19:550-571.
• [33]Alesiani D, Cicconi R, Mattei M, Montesano C, Bei R, Canini A: Cell cycle arrest and differentiation induction by 5,7-dimethoxycoumarin in melanoma cell lines. Int J Oncol 2008, 32:425-434.
• [34]Gismondi A, Lentini A, Tabolacci C, Provenzano B, Beninati S: Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16-F10 mouse melanoma cells. Amino Acids 2010, 38:257-262.
• [35]Chen YJ, Chen YY, Lin YF, Hu HY, Liao HF: Resveratrol inhibits alpha-melanocyte-stimulating hormone signaling, viability, and invasiveness in melanoma cells. Evid Based Complement Alternat Med 2013, 2013:632121.
• [36]Yajima I, Kumasaka MY, Thang ND, Goto Y, Takeda K, Iida M, Ohgami N, Tamura H, Yamanoshita O, Kawamoto Y, Furukawa K, Kato M: Molecular network associated with MITF in skin melanoma development and progression. J Skin Cancer 2011, 2011:730170.